Learning enhancement with neuropeptides

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 4, 2006, Pages 1153-1158

  Toso, Laura ^a,b   Endres, Melanie ^a   Vink, Joy ^a   Abebe, Daniel T ^a   Brenneman, Douglas E ^a   Spong, Catherine Y ^a  

^a National Institute of Child Health and Development   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Learning enhancement; Neuropeptide; Pregnancy

Indexed keywords

DEXTRO ASPARAGINYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; DEXTRO SERYLALANYLLEUCYLLEUCYLARGINYLSERYLISOLEUCYLPROLYLALANINE; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; FEMALE; GESTATION PERIOD; LATENT PERIOD; LEARNING; MAZE TEST; MOUSE; MOUSE STRAIN; NEUROPHARMACOLOGY; NONHUMAN; PERINATAL DRUG EXPOSURE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; STATISTICAL SIGNIFICANCE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; FEMALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; NEUROPEPTIDES; OLIGOPEPTIDES; PREGNANCY;

EID: 33645866177     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.12.023     Document Type: Article

References (20)

1. Beni Adani L., Gozes I., Cohen Y., Assaf Y., Steingart R.A., Brenneman D.E., et al. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J Phar Exp Ther 296 (2001) 57-63
2. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., et al. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 72 (1999) 1283-1293
3. Vink J., Auth J., Abebe D.T., Brenneman D.E., and Spong C.Y. Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol 193 Pt 1 (2005) 825-829
4. Brenneman D.E., Spong C.Y., and Gozes I. Protective peptides from novel glial proteins. Biochem Soc Trans 28 (2000) 452-455
5. Brenneman D.E., Hauser J., Neale E., Rubinraut S., Fridkin M., Davidson A., et al. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J Pharmacol Exp Ther 285 (1998) 619-627
6. Offen D., Sherki Y., Melamed E., Fridkin M., Brenneman D.E., and Gozes I. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res 854 (2000) 257-262
7. Steingart R.A., Solomon B., Brenneman D.E., Fridkin M., and Gozes I. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J Mol Neurosci 15 (2000) 137-145
8. Wilkemeyer M.F., Menkari C.E., Spong C.Y., and Charness M.E. Peptide antagonists of ethanol inhibition of L1-mediated cell-cell adhesion. J Pharmacol Exp Ther 303 (2002) 110-116
9. Spong C.Y., Abebe D.T., Gozes I., Brenenman D.E., and Hill J.M. Prevention of fetal death and growth restriction in mouse model of fetal alcohol syndrome. J Pharm Exp Ther 297 (2001) 774-779
10. Brenneman D.E., Spong C.Y., Hauser J.M., Abebe D., Pinhasov A., Golian T., et al. Protective peptides that are orally active and mechanistically nonchiral. J Pharm Exp Ther 309 (2004) 1190-1197
11. Spong C.Y., Lee S.J., McCune S.K., Gibney G., Abebe D., Brenneman D.E., et al. Regulation of posimplantation embryonic growth by maternal vasoactive intestinal peptide. Ann N Y Acad Sci 897 (1999) 101-108
12. Morris R.G.M., Garrud P., Rawlins J.P., and O'Keefe J. Place navigation in rats with hippocampal lesions. Nature 297 (1982) 681-683
13. Astur R.S., Tropp J., Sava S., Constable R.T., and Markus E.J. Sex differences and correlations in a virtual Morris water task, a virtual radial arm maze, and mental rotation. Behav Br Res 151 (2004) 103-115
14. Giese K.P., Peters M., and Vernon J. Modulation of excitability as a learning and memory mechanism: a molecular genetic perspective. Physiol Behav 73 5 (2001) 803-810
15. Guo Q., Sebastian L., Sopher B.L., Miller M.W., Glazner G.W., Martin G.M., et al. Neurotophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitoxic neurodegenerative cascades promoted by a PS1 mutation. Proc Natl Acad Sci 96 (1999) 1156-1160
16. White D.M., Walker S., Brenneman D.E., and Gozes I. CREB contributes to the increased neurite outgrowth of sensory neurons induced by vasoactive intestinal polypeptide and activity-dependent neurotrophic factor. Brai Res 868 (2000) 31-38
17. Glazner G.W., Camandola S., and Mattson M.P. Nuclear factor-kappa B mediates the cell survival-promoting action of activity-dependent neurotrophic factor peptide. J Neurochem 75 (2000) 101-108
18. th March, LA.
19. Glazner G.W., Boland F., Dresse A.E., Brenneman D.E., Gozes I., and Mattson M.P. Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death. J Neurochem 73 (1999) 2341-2347
20. Gozes I., Giladi E., Pinhasov A., Bardea A., and Brenneman D.E. Activity-dependent neurotrophic factor: Intranasal administration of femtomolar-acting peptides improve performance in a water maze. JPET 293 (2000) 1091-1098